PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663536
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663536
Covered Stent Market size was valued at USD 1,209.43 Million in 2024, expanding at a CAGR of 4.25% from 2025 to 2032.
A covered stent is a type of medical stent that includes a synthetic or biological membrane covering its surface. This covering provides additional protection and functionality compared to bare-metal stents. Covered stents are primarily used in vascular and non-vascular procedures to treat various medical conditions.
Covered Stent Market- Market Dynamics
Increasing prevalence of cardiovascular and vascular diseases, advancements in medical stent technologies are expected to propel market demand
The covered stent market is witnessing significant growth due to the increasing prevalence of cardiovascular and vascular diseases, advancements in medical technologies, and a growing aging population. Aortic aneurysms, peripheral artery disease (PAD), and other vascular complications are becoming more common globally due to unhealthy lifestyles, smoking, and high cholesterol levels. Covered stents offer a minimally invasive solution to repair blood vessels, making them highly sought after in these cases. Conditions like hypertension and diabetes exacerbate vascular problems, increasing the demand for advanced treatment options such as covered stents.
Technological advancements have led to the development of stents made from biocompatible and durable materials like PTFE and nitinol. These materials enhance the stents' flexibility, durability, and compatibility with the human body. Covered stents enable minimally invasive treatments, reducing surgical risks and recovery times compared to open surgeries, which has increased their adoption among patients and healthcare providers. Covered stents are highly effective in managing vascular injuries caused by trauma. With increasing road accidents and industrial injuries worldwide, there is a growing need for rapid and reliable vascular repair solutions. Advancements in fenestrated and branched stent-grafts have enabled the treatment of challenging vascular conditions, such as thoracoabdominal aneurysms.
Covered Stent Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.25% over the forecast period (2025-2032)
Based on Product Type segmentation, the vascular stent segment was predicted to show maximum market share in the year 2024, owing to high prevalence of cardiovascular disorders.
Based on Application segmentation, the aortic aneurysms segment was the leading Application segment in 2024, due to high prevalence of abdominal and thoracic aortic aneurysms.
Based on End User segmentation, hospitals segment was the leading End User segment in 2024, due to increased adoption of advanced solutions within hospitals to manage patient care.
On the basis of region, North America was the leading revenue generator in 2024, owing to advanced healthcare sector & regulatory approvals.
The Global Covered Stent Market is segmented on the basis of Product Type, Application, End User, and Region.
The market is divided into two categories based on Product Type: vascular stent and non-vascular stent. The vascular stent segment dominates the market. Growing incidence of vascular diseases, coronary artery diseases are boosting segment demand.
The market is divided into three categories based on the Application: aortic aneurysms, biliary stenting, and Esophageal and Gastrointestinal. The aortic aneurysms segment held the largest market share in the application segment. Covered stents are widely used in the treatment of abdominal and thoracic aortic aneurysms.
The market is divided into three categories based on End User: hospitals, specialty clinics, and ambulatory care centers. The hospitals segment dominates the market and is expected to maintain its high dominance during the forecast period. The availability of specialized expertise in handling complex medical conditions for patient care is mainly stimulating segment growth.
Covered Stent Market- Geographical Insights
Worldwide, the Covered Stent market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds the largest share in the covered stent market, primarily due to its advanced healthcare infrastructure, high adoption rate of new medical technologies, and strong presence of leading manufacturers. Europe accounts for a significant share due to increasing healthcare investments and advancements in vascular disease management. The Asia Pacific region is witnessing rapid growth due to improvements in healthcare infrastructure, increasing awareness, and a rising burden of vascular diseases. China, India are the major contributor due to its large population and increasing access to healthcare services.
The global covered stent market is experiencing steady growth, driven by the increasing prevalence of vascular diseases and advancements in medical technology. Several key players who are actively engaged in research and development to introduce innovative products and expand their market share. Companies are focusing on developing stents with improved flexibility, deliverability, and compatibility with various anatomical challenges. For instance, the introduction of stents with thinner profiles and enhanced flexibility caters to complex percutaneous coronary interventions (PCI). Obtaining regulatory approvals for new products is crucial for market expansion. Companies are actively seeking approvals from regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to launch their products in new markets.
In April 2024, Getinge formed a commercial distribution agreement with Cook Medical to introduce the iCast Covered Stent System in the U.S market.
In January 2024, W. L. Gore & Associates, Inc. got FDA approval for a updated streamlined version of their GORE VIABAHN VBX Balloon Expandable Endoprosthesis or VBX Stent Graft.